The biotechnology sector is a rapidly-evolving space, and biotech traders must always stay on top of the latest developments. Here is a roundup of several recent biotech developments that are worth keeping an eye on.
Arena Collaborates With Roivant On Nelotanserin
Arena Pharaceuticals Inc (NASDAQ: ARNA) recently announced that its subsidiary Arena Pharmaceuticals GmbH has entered into a Development, Marketing and Supply Agreement with Roivant Sciences Ltd for nelotanserin. Nelotanserin is Arena’s internally-discovered inverse agonist of the 5-HT2A receptor. Under the terms of the agreement,Roivant will now be the exclusive worldwide developer and marketer of nelotanserin.
Pfizer Acquires Interest In AM Pharma
Pfizer Inc (NYSE: PFE) announced this week that it has purchased a minority stake in AM Pharma B.V., a Dutch biopharmaceutical company that focuses on use of recombinant human Alkaline Phosphatase for treatment of inflammatory diseases.
In addition to Pfizer’s minority interest in AM, it has also secured an exclusive option to acquire AM’s remaining equity in the future.
Threshold’s Evofosfamide Granted Fast Track Status
Threshold Pharmaceuticals Inc (NASDAQ: THLD) recently announced that its drug evofosfamide has been granted…
Read the rest of this article (and all my other articles) for free on Benzinga by clicking here
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
